FLSM
TCDA

Frazier Life Sciences Management’s Tricida, Inc. Common Stock TCDA Stock Holding History

Frazier Life Sciences Management’s Portfolio TCDA Stock Details TCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,549,671
Closed -$26.7M – 49
2022
Q3 		$26.7M Buy
2,549,671
+467,578
+22% +$5.11M 2.06% 15
2022
Q2 		$20.2M Hold
2,082,093
– – 1.9% 14
2022
Q1 		$17.1M Buy
+2,082,093
New +$18.8M 1.46% 21

Other funds holding TCDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frazier Life Sciences Management's TCDA Position: Q4 2022 in Review

Frazier Life Sciences Management sold out of Tricida, Inc. Common Stock (TCDA) in Q4 2022, closing a stake of 2,549,671 shares — an estimated $26.7M sold.

Frazier Life Sciences Management first reported a position in TCDA in Q1 2022 and held it in 3 quarters. The position peaked at $26.7M in Q3 2022. 70 funds tracked by Wall St. Rank hold TCDA as of Q4 2022.

  • Frazier Life Sciences Management reported no remaining Tricida, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Frazier Life Sciences Management sold 2,549,671 Tricida, Inc. Common Stock shares in Q4 2022, an estimated $26.7M.
  • Frazier Life Sciences Management first reported a position in Tricida, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Frazier Life Sciences Management's Tricida, Inc. Common Stock position peaked at $26.7M in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q4 2022.

Based on Frazier Life Sciences Management's 13F filing for Q4 2022, filed 3 Feb 2023.